This inventor holds 5 USPTO granted patents, plus 4 CIPO patents and 3 EPO patents. Top assignees: Teijin Limited, Teijin Pharma Limited, Km Biologics Co., Ltd.. Active years: 2004-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2004 - 2018)
- Hino, JP (2015 - 2022)
Company Filing History:
4 out of 1,605 
3 out of 126 
2 out of 24 Years Active: 2004-2022
Title: Innovations of Kentaro Fujinaga
Introduction
Kentaro Fujinaga is a notable inventor based in Hino, Japan. He has made significant contributions to the field of medical materials, particularly in the development of hemostatic products. With a total of five patents to his name, Fujinaga's work has the potential to impact wound care and surgical procedures.
Latest Patents
Fujinaga's latest patents include a formed sheet product and hemostatic material. This innovation involves a polymer composition that includes proteins such as fibrinogen and thrombin, combined with polymers like aliphatic polyester and water-soluble polymers. The laminated formed sheet product consists of two layers: one made of fibrinogen and a water-soluble polymer, and the other composed of thrombin and an aliphatic polyester. These products are designed to be applied to wound sites, effectively functioning as a hemostatic material.
Career Highlights
Throughout his career, Kentaro Fujinaga has worked with prominent companies such as Teijin Limited and Teijin Pharma Limited. His experience in these organizations has allowed him to refine his expertise in polymer science and medical applications.
Collaborations
Fujinaga has collaborated with talented individuals in his field, including Yukako Kageyama and Ayuko Yamaguchi. These partnerships have likely contributed to the success of his innovative projects.
Conclusion
Kentaro Fujinaga's contributions to the field of medical materials through his patents and collaborations highlight his role as a significant inventor. His work in developing hemostatic materials showcases the potential for innovation in improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile